Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial - Olivotto, I; Oreziak, A; Barriales-Villa, R (Lancet, 2020)
et al.